STRUCTURE-FUNCTION RELATIONSHIPS OF PROTECTIN(CD59)
保护素(CD59)的结构与功能关系
基本信息
- 批准号:3366991
- 负责人:
- 金额:$ 17.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-02-01 至 1996-01-31
- 项目状态:已结题
- 来源:
- 关键词:CD antigens CHO cells binding proteins complement complement inhibitors complement pathway complementary DNA fusion gene gene expression genetic library human tissue lymphocyte membrane proteins molecular site monoclonal antibody nucleic acid sequence paroxysmal nocturnal hemoglobinuria phosphatidylinositols polymerization protein structure function site directed mutagenesis tissue /cell culture transfection
项目摘要
CD59 (protectin, membrane inhibitor of reactive lysis [MIRL]) is a glycan-
phosphatidylinositol (GPI) linked protein that is crucial in the control of
complement activation by inhibiting the polymerization of C9. It is
particularly important for cells of the blood and its lack in blood cells
in paroxysmal nocturnal hemoglobinuria is the chief cause of hemolysis and
perhaps thrombosis. Using a cDNA for CD59, we plan to characterize the
gene structure of the molecule. We plan to determine structure-function
relationships by replacing the GPI anchor with a transmembrane anchor and
to vary the length of the cytoplasmic tail in order to determine the effect
on its biological function. Using site-directed mutagenesis, we plan to
determine which of the 11 cysteines in the molecule are important for
function. We will replace segments of the molecule to determine the
functional sites. We will examine the effect of altering the carboxyl end
of the coded molecule on the fixation to the GPI anchor; specifically, we
will mutagenize the three asparagine groups as well as specific residues
within the hydrophobic region of the molecule. Finally, we will exchange
this region with that of CD55 to determine if the hydrophobic region is
protein specific. With these studies, we will have an increased
understanding of the genetics and structure-function relationships of this
important protein.
CD 59(protectin,反应性裂解的膜抑制剂[MIRL])是一种聚糖-
磷脂酰肌醇(GPI)连接的蛋白质,这是至关重要的控制
通过抑制C9的聚合来激活补体。 是
对血液细胞特别重要,
阵发性睡眠性血红蛋白尿症是溶血的主要原因,
可能是血栓 使用CD 59的cDNA,我们计划表征
分子的基因结构。 我们计划确定结构-功能
通过用跨膜锚代替GPI锚来改变关系,
改变胞质尾的长度,以确定
它的生物学功能。 利用定点突变,我们计划
确定分子中的11个半胱氨酸中的哪一个对于
功能 我们将替换分子的片段以确定
功能性网站 我们将研究改变羧基末端的影响
在GPI锚的固定上的编码分子;具体地说,我们
将诱变三个天冬酰胺基团以及特定的残基
在分子的疏水区域内。 最后,我们将交换
将该区域与CD 55的区域进行比较,以确定疏水区域是否
蛋白质特异性。 通过这些研究,我们将增加
了解这种基因的遗传学和结构-功能关系,
重要蛋白质
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WENDELL F ROSSE其他文献
WENDELL F ROSSE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WENDELL F ROSSE', 18)}}的其他基金
TOLERABILITY AND EFFECTIVENESS OF CPC111 IN SICKLE CELL ANEMIA
CPC111 在镰状细胞贫血症中的耐受性和有效性
- 批准号:
6274035 - 财政年份:1997
- 资助金额:
$ 17.91万 - 项目类别:
STRUCTURE-FUNCTION RELATIONSHIPS OF PROTECTIN(CD59)
保护素(CD59)的结构与功能关系
- 批准号:
3366990 - 财政年份:1992
- 资助金额:
$ 17.91万 - 项目类别:
TRANSFUSION TRIAL TO PREVENT PLATELET ALLOIMMUNIZATIONS
预防血小板同种免疫的输血试验
- 批准号:
3553343 - 财政年份:1989
- 资助金额:
$ 17.91万 - 项目类别:
TRANSFUSION TRIAL TO PREVENT PLATELET ALLOIMMUNIZATIONS
预防血小板同种免疫的输血试验
- 批准号:
3553345 - 财政年份:1989
- 资助金额:
$ 17.91万 - 项目类别:
TRANSFUSION TRIAL TO PREVENT PLATELET ALLOIMMUNIZATIONS
预防血小板同种免疫的输血试验
- 批准号:
3553346 - 财政年份:1989
- 资助金额:
$ 17.91万 - 项目类别:
TRANSFUSION TRIAL TO PREVENT PLATELET ALLOIMMUNIZATIONS
预防血小板同种免疫的输血试验
- 批准号:
3553344 - 财政年份:1989
- 资助金额:
$ 17.91万 - 项目类别:
相似海外基金
Manipulation and engineering of lipid metabolic pathways in CHO cells to enhance processability of cell culture supernantants
CHO 细胞中脂质代谢途径的操作和工程,以增强细胞培养上清液的可加工性
- 批准号:
2873335 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
Studentship
Glycoengineering of CHO cells to express recombinant alpha-1 antitrypsin
CHO细胞的糖工程表达重组α-1抗胰蛋白酶
- 批准号:
10484110 - 财政年份:2022
- 资助金额:
$ 17.91万 - 项目类别:
Evaluation of antibody-heterogeneity in CHO cells
CHO 细胞中抗体异质性的评估
- 批准号:
20K15105 - 财政年份:2020
- 资助金额:
$ 17.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidating the signalling pathways important for antibody production and secretion in CHO cells
阐明 CHO 细胞中抗体产生和分泌的重要信号通路
- 批准号:
2467836 - 财政年份:2020
- 资助金额:
$ 17.91万 - 项目类别:
Studentship
Combinatorial approaches to engineer CHO cells to enhance production of difficult-to-express therapeutic proteins
改造 CHO 细胞的组合方法以增强难以表达的治疗性蛋白质的产生
- 批准号:
BB/T508615/1 - 财政年份:2019
- 资助金额:
$ 17.91万 - 项目类别:
Training Grant
Development of rapid production of antibody drugs using a single-copy gene expression system in CHO cells
开发利用 CHO 细胞单拷贝基因表达系统快速生产抗体药物
- 批准号:
19K05178 - 财政年份:2019
- 资助金额:
$ 17.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Utilization of chromosomal instability in CHO cells in recombinant protein production
在重组蛋白生产中利用 CHO 细胞染色体不稳定性
- 批准号:
19K21105 - 财政年份:2018
- 资助金额:
$ 17.91万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of a novel inducible expression system for the manufacture of therapeutic proteins from CHO cells.
开发一种新型诱导表达系统,用于从 CHO 细胞生产治疗性蛋白质。
- 批准号:
104199 - 财政年份:2018
- 资助金额:
$ 17.91万 - 项目类别:
Collaborative R&D
Developing novel biosensors for monitoring antibody production in CHO cells.
开发新型生物传感器来监测 CHO 细胞中抗体的产生。
- 批准号:
1983469 - 财政年份:2018
- 资助金额:
$ 17.91万 - 项目类别:
Studentship
Cell and Process Engineering for Transient Expression of Recombinant Proteins in CHO Cells
CHO 细胞中重组蛋白瞬时表达的细胞和工艺工程
- 批准号:
2122943 - 财政年份:2018
- 资助金额:
$ 17.91万 - 项目类别:
Studentship